Literature DB >> 16404720

Proteomic analysis of mammalian basic proteins by liquid-based two-dimensional column chromatography.

Yu-Kyong Shin1, Hyoung-Joo Lee, Joon Seok Lee, Young-Ki Paik.   

Abstract

To develop a standard method for separating highly basic proteins in mammalian cells, we established a 2-D LC separation system coupled with chromatofocusing/nonporous RP column chromatography (CF/NPRPC) in a ProteomeLab PF2D system. After standardizing conditions for 2-D LC, a 2-D liquid protein map of uninfected macrophage proteins with pH range 8.3-11.3 was constructed, and then compared with a macrophage protein map made after infection with Candida albicans. The results demonstrate that 2-D LC offers both high resolution and reproducibility for separation of highly basic, macrophage proteins. After protein identification using a nano 2-D LC-MS/MS Proteomics Solution System, quantitative determination of the changes in the differentially expressed proteins (e.g., galectin-3) in C. albicans-infected macrophages was also accomplished by measuring the peak area of the chromatogram in 2-D LC. The result from this measurement of galectin-3 expression shows a 3.41-fold decrease in the infected macrophage cells, which was further confirmed by that from the RT-PCR of mRNA of galectin-3. Thus, 2-D LC coupled with CF/NPRPC could be applicable to common analysis of highly basic proteins in a high-throughput manner.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16404720     DOI: 10.1002/pmic.200500433

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  8 in total

1.  Haptoglobin is a serological biomarker for adenocarcinoma lung cancer by using the ProteomeLab PF2D combined with mass spectrometry.

Authors:  You-Kang Chang; Yu-Heng Lai; Yen Chu; Ming-Cheng Lee; Chun-Yao Huang; Semon Wu
Journal:  Am J Cancer Res       Date:  2016-08-01       Impact factor: 6.166

2.  Serum proteomic signature of human chagasic patients for the identification of novel potential protein biomarkers of disease.

Authors:  Jian-Jun Wen; M Paola Zago; Sonia Nuñez; Shivali Gupta; Federico Nuñez Burgos; Nisha Jain Garg
Journal:  Mol Cell Proteomics       Date:  2012-04-27       Impact factor: 5.911

3.  Proteomics and mass spectrometry: what have we learned about the heart?

Authors:  Shaan Chugh; Colin Suen; Anthony Gramolini
Journal:  Curr Cardiol Rev       Date:  2010-05

4.  Recent advances in proteomics and cancer biomarker discovery.

Authors:  Gary Guishan Xiao; Robert R Recker; Hong-Wen Deng
Journal:  Clin Med Oncol       Date:  2008-02-09

5.  The utilization of Triton X-100 for enhanced two-dimensional liquid-phase proteomics.

Authors:  Mina Kim; Sang-Hee Lee; Jiho Min; Fumihisa Kobayashi; Hyun-Ju Um; Yang-Hoon Kim
Journal:  J Biomed Biotechnol       Date:  2011-10-16

6.  Schizophrenia proteomics: biomarkers on the path to laboratory medicine?

Authors:  Shaheen Emmanuel Lakhan
Journal:  Diagn Pathol       Date:  2006-07-17       Impact factor: 2.644

7.  Multidimensional protein fractionation using ProteomeLab PF 2D for profiling amyotrophic lateral sclerosis immunity: A preliminary report.

Authors:  Joshua D Schlautman; Wojciech Rozek; Robert Stetler; R Lee Mosley; Howard E Gendelman; Pawel Ciborowski
Journal:  Proteome Sci       Date:  2008-09-12       Impact factor: 2.480

Review 8.  An Omics Perspective on Candida Infections: Toward Next-Generation Diagnosis and Therapy.

Authors:  S P Smeekens; F L van de Veerdonk; M G Netea
Journal:  Front Microbiol       Date:  2016-02-16       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.